Background: Serum protein biomarkers are used to diagnose, monitor treatment response, and to differentiate various forms of chronic enteropathies (CE) in humans. The utility of liquid biopsy proteomic approaches has not been examined in cats.
Hypothesis/objectives: To explore the serum proteome in cats to identify markers differentiating healthy cats from cats with CE.